Dual-ferroptosis induction-based microneedle patches for enhanced chemodynamic/photothermal combination therapy against triple-negative breast cancer
Open Access
- 31 May 2025
- journal article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 15 (8) , 4210-4224
Abstract
No abstract availableKeywords
Funding Information
- Anhui Provincial Natural Science Foundation (2208085Y24)
- Ministry of Industry and Information Technology of the People's Republic of China (MCD-2023-1-14)
- Anhui province Department of Education (2024AH020005)
- Smoking Research Foundation (S13)
This publication has 32 references indexed in Scilit:
- Redox-regulating nanotherapeutics potentiating ferroptosis-driven cancer treatmentChemical Engineering Journal, 2024
- Coordinating effect of ferroptosis and in situ disulfiram toxification for enhanced cancer therapyChemical Engineering Journal, 2024
- Nanosized Prussian blue and its analogs for bioimaging and cancer theranosticsActa Biomaterialia, 2024
- Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancerBiomaterials, 2023
- From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinomaBiomedicine & Pharmacotherapy, 2023
- Engineering Hyaluronic Acid Microneedles Loaded with Mn2+ and Temozolomide for Topical Precision Therapy of MelanomaAdvanced Healthcare Materials, 2023
- Injectable alginate hydrogel promotes antitumor immunity through glucose oxidase and Fe3+ amplified RSL3-induced ferroptosisCarbohydrate Polymers, 2023
- Microneedle Patch Integrated with Porous Silicon Confined Dual Nanozymes for Synergistic and Hyperthermia‐Enhanced Nanocatalytic Ferroptosis Treatment of MelanomaAdvanced Functional Materials, 2023
- Multifunctional Prussian blue-based nanomaterials: Preparation, modification, and theranostic applicationsCoordination Chemistry Reviews, 2020
- Breast Cancer TreatmentJAMA, 2019